BDOcterio™ 30 (Monthly Depot)

Brand Name: BDOcterio™ 30 (Monthly Depot)
Active Composition: Octreotide Acetate (equivalent to Octreotide base 30 mg)
Manufacturer/Marketer: BDR Pharmaceuticals Internationals Pvt. Ltd.

Product Description

Medical Info
BDOcterio 30 mg Injection is a prolonged-release parenteral medication containing Octreotide, a synthetic analog of the naturally occurring hormone somatostatin. It functions by suppressing the body’s overproduction of specific hormones, such as growth hormone, insulin, and glucagon. Primarily indicated for managing acromegaly (a condition causing abnormal tissue growth), it significantly reduces structural and physiological symptoms. Furthermore, BDOcterio is utilized to control severe diarrhea and flushing associated with gastrointestinal neuroendocrine tumors, such as carcinoid tumors and VIPomas. It also plays a vital role in preventing post-pancreatic surgery complications and managing bleeding esophageal varices in chronic liver diseases. Administered strictly via intramuscular injection by medical professionals, it requires temperature-controlled refrigerator storage to maintain stability.
Precautions & Warnings

Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.

Storage

Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.

Status

Keep all medicines out of reach of children.

Category: